Cancer induced bone pain

BMJ (Online)

Volumn 350, Issue , 2015, Pages

  Kane, Christopher M ^a   Hoskin, Peter ^b   Bennett, Michael I ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; BUPRENORPHINE; CODEINE; DENOSUMAB; FENTANYL; IBANDRONIC ACID; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PLACEBO; RADIOISOTOPE; TRAMADOL; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT; MONOCLONAL ANTIBODY; NARCOTIC ANALGESIC AGENT;

ADVANCED CANCER; BEHAVIOR MODIFICATION; BONE METASTASIS; BONE PAIN; BREAKTHROUGH PAIN; BREAST CANCER; CANCER INDUCED BONE PAIN; CANCER PAIN; CLINICAL FEATURE; CONSTIPATION; HUMAN; LEUKOPENIA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; OPIATE ADDICTION; PATHOLOGIC FRACTURE; PATIENT REFERRAL; REVIEW; SELF CARE; SPINAL CORD COMPRESSION; THROMBOCYTOPENIA; TRANSCUTANEOUS NERVE STIMULATION; ADJUVANT CHEMOTHERAPY; ALTERNATIVE MEDICINE; BONE DISEASES; BONE NEOPLASMS; COMPLICATION; PAIN; PATIENT EDUCATION; PROCEDURES; SECONDARY;

ANALGESICS, OPIOID; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMPLEMENTARY THERAPIES; DIPHOSPHONATES; HUMANS; PAIN; PATIENT EDUCATION AS TOPIC; REFERRAL AND CONSULTATION;

EID: 84921921271     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h315     Document Type: Review

References (34)

1. Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 1996;64:107-14.
2. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 1999;82:263-74.
3. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12(20 Pt 2):6243s-49s.
4. Falk S, Dickenson AH. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol 2014;32:1647-54.
5. Middlemiss T, Laird BJ, Fallon MT. Mechanisms of cancer-induced bone pain. Clin Oncol 2011;23:387-92.
6. Davies A, Buchanan A, Zeppetella G, Porta-Sales J, Likar R, Weismayr W, et al. Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manage 2013;46:619-28.
7. White BD, Stirling AJ, Paterson E, Asquith-Coe K, Melder A. Diagnosis and management of patients at risk of or with metastatic spinal cord compression: summary of NICE guidance. BMJ 2008;337:a2538.
8. Chaichana KL, Woodworth GF, Sciubba DM, McGirt MJ, Witham TJ, Bydon A, et al Predictors of ambulatory function after decompressive surgery for metastatic epidural spinal cord compression. Neurosurgery 2008;62:683-92; discussion 83-92.
9. Brown PD, Stafford SL, Schild SE, Martenson JA, Schiff D. Metastatic spinal cord compression in patients with colorectal cancer. J Neuro-oncol 1999;44:175-80.
10. World Health Organization. Cancer pain relief. 2nd ed. WHO, 1996. http://whqlibdoc.who.int/publications/9241544821.pdf.
11. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 1995;63:65-76.
12. Bennet MI. What evidence do we have that the WHO analgesic ladder is effective in cancer pain? In: McQuay HJ, Moore R, Kalso E, eds. Systematic reviews in pain research; methodology refined. IASP Press, 2008.
13. Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med 2012;26:305-12.
14. McNicol E, Strassels SA, Goudas L, Lau J, Carr DB. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 2005;1:CD005180.
15. Bennett MI, Graham J, Schmidt-Hansen M, Prettyjohns M Arnold S. Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance. BMJ 2012;344:e2806.
16. Klepstad P, Kaasa S, Jystad A, Hval B, Borchgrevink PC. Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain 2003;101:193-8.
17. National Institute for Health and Care Excellence. Opioids in palliative care. (Glinical guideline 140.) 2012. www.nice.org.uk/cg140.
18. Riley J, Branford R, Droney J, Gretton S, Sato H, Kennett A, et al. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial. J Pain Sympt Manage 2014; published online 26 Jun. doi: 10.1016/j.jpainsymman.2014.05.021.
19. Jandhyala R, Fullarton JR, Bennett MI. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. J Pain Sympt Manage 2013;46:573-80.
20. Davis MP. Efficacy of rapid-onset oral fentanyl: what does it mean? J Pain Sympt Manage 2014;48:e2-3.
21. Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat Med 2011;25:553-9.
22. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 2013;31:3076-82.
23. Paulsen O, Klepstad P, Rosland JH, Aass N, Albert E, Fayers P, et al. Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. J Clin Oncol 2014;32:3221-8.
24. Dennis K, Makhani L, Zeng L, Lam H, Chow E. Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials. Radiother Oncol 2013;106:5-14.
25. Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol 2012;24:112-24.
26. Chow E, Meyer RM, Chen BE, van der Linden YM, Roos D, Hartsell WF, et al. Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial. J Clin Oncol 2014; published online 27 Oct.
27. Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS et al. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol 2014;15:164-71.
28. National Institute for Health and Care Excellence Advancerd breast cancer. (Clinical guideline 81). 2014. www.nice.org.uk/guidance/cg81.
29. Gralow J, Tripathy D. Managing metastatic bone pain: the role of bisphosphonates. J Pain Sympt Manage 2007;33:462-72.
30. Hoskin P, Sundar S, Reczko K, Forsyth S, Mithal N, Sizer B et al. A Multicentre Randomised Trial of Ibandronate Compared to Single Dose Radiotherapy for Localised Metastatic Bone Pain in Prostate Cancer (RIB). Eur J Cancer 2011;47:6.
31. Wong R, Wiffen PJ. Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002;2:CD002068.
32. Mhaskar R, Redzepovic J, Wheatley K, Clark OA, Miladinovic B, Glasmacher A, et al. Bisphosphonates in multiple myeloma: a network meta-analysis. Cochrane Database Syst Rev 2012;5:CD003188.
33. Stopeck AT, Lipton A, Body JJ, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 2010;28:5132-9.
34. Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev 2012;3:CD006276.